BR
Braxia Scientific Corp.
BRAXF · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $39.6K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.02x
P/S 0.02x
EV/EBITDA N/A
Growth
78 /100
Growing Book val. growth 51.42%
Rev. growth 1,971.39%
FCF growth N/A
Profitability
1 /100
Weak Net margin 697.48%
Op. margin 397.00%
FCF margin 440.60%
Quality
9 /100
Poor ROA 338.35%
Asset turnover 0.49x
ROIC 408.30%
Debt
55 /100
Moderate Current ratio 1.00x
Int. coverage -743.78x
Debt/Equity 0.13x
Stability
10 /100
Unstable Rev. volatility 274,535.87%
EPS volatility 7,320.63%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o BRAXF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Peter Rizakos
Employees
5
Headquarters
Toronto